Royal Marsden NHS Foundation Trust: Rectal Neoplasms trials

The registry lists 10 Rectal Neoplasms studies with Royal Marsden NHS Foundation Trust as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided RadiotherapyRecruitingNCT06854679Not applicable
• iSCORE: Immunotherapy Sequencing in COlon and REctal CancerActive, not recruitingNCT03867799Phase 2
• Mri IN STaging REctal Polyp PlanesStatus unknownNCT02532803Not applicable
• Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and ImagingCompletedNCT02486094
• Low Rectal Cancer Study (MERCURY II)Status unknownNCT02005965
• Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialStatus unknownNCT01995942
• Evaluation of Bladder Volumes in Patients Receiving Radiotherapy to the Rectum, Using Kilovoltage Cone-beam ImagingStatus unknownNCT01033682
• Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerStatus unknownNCT00383695Phase 2
• Prospective Study in Pelvic Radiotherapy PatientsCompletedNCT00220181
• A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2